Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 1097 record(s)

Req # A-2020-000202

Adverse Reaction Reports (AERs). Report numbers: 000722295, 000722243, E2B_02407239, E2B_02412024, E2B_02413346, E2B_02421333, E2B_02429137, 000725392, 000726356, 000725414, E2B_02472563.

Organization: Health Canada

112 page(s)
December 2020

Req # A-2020-000209

Adverse Reaction Reports (AERs). Report numbers: E2B_02774611, E2B_02784536, E2B_02786964, E2B_02806078, E2B_02812036, E2B_02815264.

Organization: Health Canada

94 page(s)
December 2020

Req # A-2020-000221

Adverse Reaction Reports (AERs) for JANUVIA. Report numbers: 000649936, 000650406, 000655227, 000659210, 000662670, E2B_00280827, E2B_00406750, E2B_00469795, 000678023, 000681096, E2B_00826528.

Organization: Health Canada

223 page(s)
December 2020

Req # A-2020-000254

Adverse Reaction Reports (AERs) for LEFLUNOMIDE. Report numbers: E2B_02764906, E2B_02767301, E2B_02795974, E2B_02803857, E2B_02804702, E2B_02807272, E2B_02808413, E2B_02704907, E2B_02714284, E2B_02725329, E2B_02740979, E2B_02731286, E2B_02742440, E2B_02790914, E2B_02791402.

Organization: Health Canada

242 page(s)
December 2020

Req # A-2020-000295

Adverse Reaction Reports (AERs). Report numbers: E2B_02935664, E2B_02935144, E2B_02935688, E2B_02968785, E2B_02989441, E2B_02966407, E2B_02934111, E2B_02953752, E2B_02956411, E2B_02956394, E2B_02960909, E2B_02960895, E2B_02970445, E2B_02970340, E2B_02981231, E2B_02989560.

Organization: Health Canada

241 page(s)
December 2020

Req # A-2020-000332

Adverse Reaction Reports (AERs) for Gammagard S/D. Report numbers: E2B_02893363, E2B_02893580, E2B_02908946.

Organization: Health Canada

58 page(s)
December 2020

Req # A-2020-000616

Adverse Reaction Reports (AERs). Report numbers: 000910675, 000912665, E2B_03055544, E2B_03056588.

Organization: Health Canada

41 page(s)
December 2020

Req # A-2020-000698

Adverse Reaction Report (AER). Report number: 000909840.

Organization: Health Canada

2 page(s)
December 2020

Req # A-2020-000357

Adverse Reaction Reports (AERs) for LEFLUNOMIDE. Report numbers: E2B_02872133, E2B_02870857, E2B_02971194, E2B_02934136, E2B_02934162, E2B_02843612, E2B_02901068, E2B_02844913, 731345, E2B_02936598, E2B_02937155, E2B_02940662, E2B_02942069, E2B_02948725, E2B_02948736, E2B_02895831, E2B_02948829, 731316, 731377.

Organization: Health Canada

269 page(s)
December 2020

Req # A-2020-000407

Adverse Reaction Reports (AERs). Report numbers: E2B_03006673, E2B_03015119, E2B_03017606, E2B_03026741.

Organization: Health Canada

88 page(s)
December 2020
Date modified: